OR

Browse By

Evaluation of Tolebrutinib as a novel disease-modifying therapeutic for Parkinson's disease (2022–2024)

Grant type:
The Michael J Fox Foundation Therapeutic Pipeline Program
Researchers:

  • Dr Richard Gordon

    Honorary Associate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine

  • Dr Rob Adam

    Trials Medical Specialist
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
The Michael J Fox Foundation for Parkinsons Research